DSCSA requires pharmacies to work with authorized trading partners and maintain product-tracing documentation for covered transactions. AccordRx is designed to bring those safeguards into the marketplace workflow — so records stay connected to the trade without a separate paper chase.
Trade With Confidence
Product-tracing documentation has traditionally been described as the T3: Transaction Information, Transaction History, and Transaction Statement. Enhanced DSCSA tracing now emphasizes secure, interoperable electronic exchange of Transaction Information and Transaction Statements at the package level.
The federal requirement to provide and receive Transaction History sunset in 2023. It remains useful chain-of-custody context, while current enhanced tracing centers on electronic TI and TS exchange.
Review FDA product-tracing guidanceThe product and sale details: product name, strength and dosage form, NDC, container size, lot number, quantity, and transaction and shipment dates.
How AccordRx supports it: AccordRx is designed to capture listing data — including lot and expiration data when provided — and associate it with the transaction.
The historical chain-of-custody record tracing the product through the supply chain.
How AccordRx supports it: AccordRx captures and retains transaction records and seller attestations that support chain-of-custody documentation.
The seller’s attestation that it is authorized, the product is legitimate, and the information provided is accurate.
How AccordRx supports it: Sellers complete a transaction statement as part of the sale, and AccordRx retains it for both parties.
AccordRx is a closed marketplace. Participation is limited to pharmacy members that complete AccordRx’s verification process before they can list, browse, or buy.
Every participant must complete pharmacy verification before entering the marketplace.
AccordRx’s onboarding workflow is built to review pharmacy licensure and authorized-trading-partner eligibility before a first trade.
The marketplace is not open to the public or to participants outside the pharmacy verification process.
As a buyer, you meet sellers inside a marketplace built around verified pharmacy participation.
AccordRx is designed to keep transaction documentation connected to the trade and available for export, so responding to an audit or inquiry does not begin with reconstructing the record.
Keep your compliance archive complete. DSCSA generally requires pharmacies to retain required product-tracing documentation for six years. Export your AccordRx records and confirm the platform’s current retention terms with the AccordRx team.
AccordRx is designed with layered safeguards and controlled access for marketplace and regulatory data. Specific infrastructure controls should be confirmed with the AccordRx security team.
AccordRx is building toward package-level electronic traceability, including GTIN capture and EPCIS-based data exchange aligned with GS1 standards.
Straightforward answers about product tracing, recordkeeping, and how AccordRx supports your compliance workflow.
DSCSA product-tracing requirements generally apply when one pharmacy sells covered prescription drugs to another, except for a transfer to fill a specific patient need. State licensure and other requirements can also apply. AccordRx is designed to support required documentation; pharmacies remain responsible for their legal obligations.
Participation is limited to pharmacy members that complete AccordRx’s verification process before they can trade. Contact the AccordRx team for the current verification sources and review criteria.
AccordRx is designed to connect Transaction Information, the seller’s Transaction Statement, shipment details, and related trade records to the transaction. Chain-of-custody context is retained where applicable.
DSCSA generally requires pharmacies to retain required product-tracing documentation for six years. AccordRx records are designed to be available for export with the trade; confirm the platform’s current retention terms before relying on it as your sole archive.
Stop using the product, segregate or quarantine it under your pharmacy’s suspect-product procedures, and contact AccordRx support so the issue can be documented. Follow applicable investigation and notification requirements if the product is determined to be illegitimate.
